Cargando…
A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications
In dividing cells, the two aims a gene therapeutic approach should accomplish are efficient nuclear delivery and retention of therapeutic DNA. For stable transgene expression, therapeutic DNA can either be maintained by somatic integration or episomal persistence of which the latter approach would d...
Autores principales: | Voigtlander, Richard, Haase, Rudolf, Mück-Hausl, Martin, Zhang, Wenli, Boehme, Philip, Lipps, Hans-Joachim, Schulz, Eric, Baiker, Armin, Ehrhardt, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650243/ https://www.ncbi.nlm.nih.gov/pubmed/23549553 http://dx.doi.org/10.1038/mtna.2013.11 |
Ejemplares similares
-
Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses
por: Mück-Häusl, Martin, et al.
Publicado: (2015) -
A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration
por: Boehme, Philip, et al.
Publicado: (2016) -
A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions
por: Tsoukas, Raphael L., et al.
Publicado: (2022) -
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
por: Gao, Jian, et al.
Publicado: (2020) -
Identification of the minimal replicon and the origin of replication of the crenarchaeal plasmid pRN1
por: Berkner, Silvia, et al.
Publicado: (2014)